nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—CYP2E1—Parkinson's disease	0.284	0.443	CbGaD
Carvedilol—CYP2D6—Parkinson's disease	0.209	0.325	CbGaD
Carvedilol—ABCB1—Parkinson's disease	0.149	0.232	CbGaD
Carvedilol—VCAM1—tongue—Parkinson's disease	0.00472	0.0383	CbGeAlD
Carvedilol—HIF1A—nerve—Parkinson's disease	0.00465	0.0377	CbGeAlD
Carvedilol—HIF1A—hindbrain—Parkinson's disease	0.00348	0.0283	CbGeAlD
Carvedilol—GJA1—hindbrain—Parkinson's disease	0.00338	0.0274	CbGeAlD
Carvedilol—NPPB—cardiovascular system—Parkinson's disease	0.00272	0.0221	CbGeAlD
Carvedilol—HIF1A—embryo—Parkinson's disease	0.00218	0.0177	CbGeAlD
Carvedilol—GJA1—embryo—Parkinson's disease	0.00211	0.0171	CbGeAlD
Carvedilol—HIF1A—brainstem—Parkinson's disease	0.002	0.0162	CbGeAlD
Carvedilol—GJA1—brainstem—Parkinson's disease	0.00194	0.0157	CbGeAlD
Carvedilol—HIF1A—forebrain—Parkinson's disease	0.00193	0.0156	CbGeAlD
Carvedilol—GJA1—forebrain—Parkinson's disease	0.00187	0.0152	CbGeAlD
Carvedilol—NPPB—head—Parkinson's disease	0.00184	0.015	CbGeAlD
Carvedilol—SELE—cardiovascular system—Parkinson's disease	0.00184	0.0149	CbGeAlD
Carvedilol—NPPB—nervous system—Parkinson's disease	0.00175	0.0142	CbGeAlD
Carvedilol—VCAM1—cardiovascular system—Parkinson's disease	0.00169	0.0137	CbGeAlD
Carvedilol—NPPB—central nervous system—Parkinson's disease	0.00168	0.0137	CbGeAlD
Carvedilol—HIF1A—cardiovascular system—Parkinson's disease	0.00163	0.0132	CbGeAlD
Carvedilol—NDUFC2—forebrain—Parkinson's disease	0.00163	0.0132	CbGeAlD
Carvedilol—GJA1—cardiovascular system—Parkinson's disease	0.00158	0.0128	CbGeAlD
Carvedilol—SELE—medulla oblongata—Parkinson's disease	0.00157	0.0128	CbGeAlD
Carvedilol—VCAM1—medulla oblongata—Parkinson's disease	0.00145	0.0117	CbGeAlD
Carvedilol—SELE—midbrain—Parkinson's disease	0.00144	0.0117	CbGeAlD
Carvedilol—SELE—spinal cord—Parkinson's disease	0.0014	0.0114	CbGeAlD
Carvedilol—HIF1A—medulla oblongata—Parkinson's disease	0.00139	0.0113	CbGeAlD
Carvedilol—NDUFC2—cardiovascular system—Parkinson's disease	0.00137	0.0112	CbGeAlD
Carvedilol—GJA1—medulla oblongata—Parkinson's disease	0.00135	0.011	CbGeAlD
Carvedilol—NPPB—brain—Parkinson's disease	0.00134	0.0109	CbGeAlD
Carvedilol—VCAM1—midbrain—Parkinson's disease	0.00132	0.0107	CbGeAlD
Carvedilol—ADRA2A—peripheral nervous system—Parkinson's disease	0.0013	0.0106	CbGeAlD
Carvedilol—VCAM1—spinal cord—Parkinson's disease	0.00129	0.0105	CbGeAlD
Carvedilol—HIF1A—midbrain—Parkinson's disease	0.00127	0.0103	CbGeAlD
Carvedilol—SELE—head—Parkinson's disease	0.00125	0.0101	CbGeAlD
Carvedilol—HIF1A—spinal cord—Parkinson's disease	0.00124	0.0101	CbGeAlD
Carvedilol—GJA1—midbrain—Parkinson's disease	0.00123	0.01	CbGeAlD
Carvedilol—GJA1—spinal cord—Parkinson's disease	0.0012	0.00977	CbGeAlD
Carvedilol—SELE—nervous system—Parkinson's disease	0.00118	0.00959	CbGeAlD
Carvedilol—NDUFC2—medulla oblongata—Parkinson's disease	0.00117	0.00954	CbGeAlD
Carvedilol—VCAM1—head—Parkinson's disease	0.00115	0.0093	CbGeAlD
Carvedilol—SELE—central nervous system—Parkinson's disease	0.00114	0.00923	CbGeAlD
Carvedilol—Tamsulosin—HTR7—Parkinson's disease	0.00112	0.163	CrCbGaD
Carvedilol—SELE—cerebellum—Parkinson's disease	0.00111	0.00902	CbGeAlD
Carvedilol—HIF1A—head—Parkinson's disease	0.0011	0.00895	CbGeAlD
Carvedilol—VCAM1—nervous system—Parkinson's disease	0.00109	0.00882	CbGeAlD
Carvedilol—NDUFC2—midbrain—Parkinson's disease	0.00107	0.00872	CbGeAlD
Carvedilol—GJA1—head—Parkinson's disease	0.00107	0.00868	CbGeAlD
Carvedilol—Tamsulosin—DRD3—Parkinson's disease	0.00105	0.153	CrCbGaD
Carvedilol—NDUFC2—spinal cord—Parkinson's disease	0.00105	0.0085	CbGeAlD
Carvedilol—VCAM1—central nervous system—Parkinson's disease	0.00105	0.00849	CbGeAlD
Carvedilol—HIF1A—nervous system—Parkinson's disease	0.00105	0.00849	CbGeAlD
Carvedilol—GJA1—nervous system—Parkinson's disease	0.00101	0.00823	CbGeAlD
Carvedilol—HIF1A—central nervous system—Parkinson's disease	0.00101	0.00817	CbGeAlD
Carvedilol—ADRA1A—hindbrain—Parkinson's disease	0.001	0.00812	CbGeAlD
Carvedilol—HIF1A—cerebellum—Parkinson's disease	0.000984	0.00799	CbGeAlD
Carvedilol—GJA1—central nervous system—Parkinson's disease	0.000976	0.00793	CbGeAlD
Carvedilol—ADRA1D—forebrain—Parkinson's disease	0.000964	0.00782	CbGeAlD
Carvedilol—GJA1—cerebellum—Parkinson's disease	0.000954	0.00775	CbGeAlD
Carvedilol—VEGFA—spinal cord—Parkinson's disease	0.00095	0.00772	CbGeAlD
Carvedilol—NDUFC2—head—Parkinson's disease	0.000931	0.00756	CbGeAlD
Carvedilol—SELE—brain—Parkinson's disease	0.000903	0.00733	CbGeAlD
Carvedilol—Bopindolol—HTR1A—Parkinson's disease	0.000889	0.13	CrCbGaD
Carvedilol—NDUFC2—nervous system—Parkinson's disease	0.000883	0.00717	CbGeAlD
Carvedilol—Tamsulosin—HTR1A—Parkinson's disease	0.000855	0.125	CrCbGaD
Carvedilol—NDUFC2—central nervous system—Parkinson's disease	0.00085	0.0069	CbGeAlD
Carvedilol—NDUFC2—cerebellum—Parkinson's disease	0.000831	0.00674	CbGeAlD
Carvedilol—VCAM1—brain—Parkinson's disease	0.00083	0.00674	CbGeAlD
Carvedilol—HIF1A—brain—Parkinson's disease	0.000799	0.00649	CbGeAlD
Carvedilol—GJA1—brain—Parkinson's disease	0.000775	0.00629	CbGeAlD
Carvedilol—VEGFA—cerebellum—Parkinson's disease	0.000753	0.00612	CbGeAlD
Carvedilol—Tamsulosin—DRD2—Parkinson's disease	0.000726	0.106	CrCbGaD
Carvedilol—ADRB1—forebrain—Parkinson's disease	0.0007	0.00568	CbGeAlD
Carvedilol—NDUFC2—brain—Parkinson's disease	0.000675	0.00548	CbGeAlD
Carvedilol—VEGFA—brain—Parkinson's disease	0.000612	0.00497	CbGeAlD
Carvedilol—ADRB1—cardiovascular system—Parkinson's disease	0.000592	0.00481	CbGeAlD
Carvedilol—CYP2D6—hindbrain—Parkinson's disease	0.000589	0.00478	CbGeAlD
Carvedilol—ADRA1A—brainstem—Parkinson's disease	0.000573	0.00466	CbGeAlD
Carvedilol—ADRA1B—head—Parkinson's disease	0.000564	0.00458	CbGeAlD
Carvedilol—ADRA1A—forebrain—Parkinson's disease	0.000553	0.00449	CbGeAlD
Carvedilol—ADRA1D—head—Parkinson's disease	0.000552	0.00448	CbGeAlD
Carvedilol—ADRA1B—nervous system—Parkinson's disease	0.000535	0.00434	CbGeAlD
Carvedilol—KCNH2—forebrain—Parkinson's disease	0.000535	0.00434	CbGeAlD
Carvedilol—Ranolazine—CYP2D6—Parkinson's disease	0.000533	0.0777	CrCbGaD
Carvedilol—ADRA1D—nervous system—Parkinson's disease	0.000523	0.00425	CbGeAlD
Carvedilol—ADRA1B—central nervous system—Parkinson's disease	0.000515	0.00418	CbGeAlD
Carvedilol—Tamsulosin—CYP2D6—Parkinson's disease	0.000513	0.0748	CrCbGaD
Carvedilol—ADRA1D—central nervous system—Parkinson's disease	0.000504	0.00409	CbGeAlD
Carvedilol—ADRA1A—cardiovascular system—Parkinson's disease	0.000468	0.0038	CbGeAlD
Carvedilol—KCNH2—cardiovascular system—Parkinson's disease	0.000452	0.00367	CbGeAlD
Carvedilol—ADRA2A—forebrain—Parkinson's disease	0.000421	0.00342	CbGeAlD
Carvedilol—ADRA1B—brain—Parkinson's disease	0.000409	0.00332	CbGeAlD
Carvedilol—ADRB1—head—Parkinson's disease	0.000401	0.00325	CbGeAlD
Carvedilol—ADRA1D—brain—Parkinson's disease	0.0004	0.00325	CbGeAlD
Carvedilol—PTGS1—forebrain—Parkinson's disease	0.000397	0.00322	CbGeAlD
Carvedilol—KCNH2—medulla oblongata—Parkinson's disease	0.000386	0.00314	CbGeAlD
Carvedilol—ADRA2C—medulla oblongata—Parkinson's disease	0.000381	0.00309	CbGeAlD
Carvedilol—ADRB1—nervous system—Parkinson's disease	0.00038	0.00309	CbGeAlD
Carvedilol—CYP2C9—cardiovascular system—Parkinson's disease	0.000367	0.00298	CbGeAlD
Carvedilol—ADRB1—central nervous system—Parkinson's disease	0.000366	0.00297	CbGeAlD
Carvedilol—KCNH2—midbrain—Parkinson's disease	0.000353	0.00287	CbGeAlD
Carvedilol—ADRA2C—midbrain—Parkinson's disease	0.000348	0.00283	CbGeAlD
Carvedilol—CYP2E1—cardiovascular system—Parkinson's disease	0.000348	0.00283	CbGeAlD
Carvedilol—KCNH2—spinal cord—Parkinson's disease	0.000344	0.0028	CbGeAlD
Carvedilol—ADRA2C—spinal cord—Parkinson's disease	0.00034	0.00276	CbGeAlD
Carvedilol—CYP2D6—brainstem—Parkinson's disease	0.000338	0.00274	CbGeAlD
Carvedilol—PTGS1—cardiovascular system—Parkinson's disease	0.000335	0.00272	CbGeAlD
Carvedilol—Propranolol—HTR1A—Parkinson's disease	0.000333	0.0486	CrCbGaD
Carvedilol—CYP2D6—forebrain—Parkinson's disease	0.000326	0.00265	CbGeAlD
Carvedilol—ADRA1A—head—Parkinson's disease	0.000317	0.00257	CbGeAlD
Carvedilol—KCNH2—head—Parkinson's disease	0.000306	0.00248	CbGeAlD
Carvedilol—ADRA2A—medulla oblongata—Parkinson's disease	0.000304	0.00247	CbGeAlD
Carvedilol—ADRA2C—head—Parkinson's disease	0.000302	0.00245	CbGeAlD
Carvedilol—ADRA1A—nervous system—Parkinson's disease	0.0003	0.00244	CbGeAlD
Carvedilol—CYP2E1—medulla oblongata—Parkinson's disease	0.000297	0.00241	CbGeAlD
Carvedilol—Propafenone—CYP2D6—Parkinson's disease	0.000292	0.0426	CrCbGaD
Carvedilol—ADRB1—brain—Parkinson's disease	0.00029	0.00236	CbGeAlD
Carvedilol—KCNH2—nervous system—Parkinson's disease	0.00029	0.00236	CbGeAlD
Carvedilol—ADRA1A—central nervous system—Parkinson's disease	0.000289	0.00235	CbGeAlD
Carvedilol—ADRA2C—nervous system—Parkinson's disease	0.000286	0.00232	CbGeAlD
Carvedilol—ADRA1A—cerebellum—Parkinson's disease	0.000283	0.0023	CbGeAlD
Carvedilol—KCNH2—central nervous system—Parkinson's disease	0.000279	0.00227	CbGeAlD
Carvedilol—ADRA2A—midbrain—Parkinson's disease	0.000278	0.00226	CbGeAlD
Carvedilol—ADRA2C—central nervous system—Parkinson's disease	0.000276	0.00224	CbGeAlD
Carvedilol—KCNH2—cerebellum—Parkinson's disease	0.000273	0.00222	CbGeAlD
Carvedilol—ADRA2A—spinal cord—Parkinson's disease	0.000271	0.0022	CbGeAlD
Carvedilol—ADRA2C—cerebellum—Parkinson's disease	0.000269	0.00219	CbGeAlD
Carvedilol—CYP2E1—spinal cord—Parkinson's disease	0.000265	0.00215	CbGeAlD
Carvedilol—ABCB1—embryo—Parkinson's disease	0.000265	0.00215	CbGeAlD
Carvedilol—CYP1A1—head—Parkinson's disease	0.000258	0.0021	CbGeAlD
Carvedilol—PTGS1—spinal cord—Parkinson's disease	0.000256	0.00207	CbGeAlD
Carvedilol—CYP1A1—nervous system—Parkinson's disease	0.000245	0.00199	CbGeAlD
Carvedilol—ADRA2A—head—Parkinson's disease	0.000241	0.00196	CbGeAlD
Carvedilol—CYP1A1—central nervous system—Parkinson's disease	0.000236	0.00192	CbGeAlD
Carvedilol—CYP2E1—head—Parkinson's disease	0.000236	0.00191	CbGeAlD
Carvedilol—ABCB1—forebrain—Parkinson's disease	0.000234	0.0019	CbGeAlD
Carvedilol—ADRA1A—brain—Parkinson's disease	0.00023	0.00186	CbGeAlD
Carvedilol—ADRA2A—nervous system—Parkinson's disease	0.000228	0.00185	CbGeAlD
Carvedilol—PTGS1—head—Parkinson's disease	0.000227	0.00184	CbGeAlD
Carvedilol—CYP2E1—nervous system—Parkinson's disease	0.000223	0.00181	CbGeAlD
Carvedilol—KCNH2—brain—Parkinson's disease	0.000222	0.0018	CbGeAlD
Carvedilol—ADRA2A—central nervous system—Parkinson's disease	0.00022	0.00179	CbGeAlD
Carvedilol—ADRA2C—brain—Parkinson's disease	0.000219	0.00178	CbGeAlD
Carvedilol—PTGS1—nervous system—Parkinson's disease	0.000215	0.00175	CbGeAlD
Carvedilol—CYP2E1—central nervous system—Parkinson's disease	0.000215	0.00175	CbGeAlD
Carvedilol—ADRA2A—cerebellum—Parkinson's disease	0.000215	0.00175	CbGeAlD
Carvedilol—CYP2E1—cerebellum—Parkinson's disease	0.00021	0.00171	CbGeAlD
Carvedilol—Propafenone—ABCB1—Parkinson's disease	0.000209	0.0304	CrCbGaD
Carvedilol—PTGS1—central nervous system—Parkinson's disease	0.000207	0.00168	CbGeAlD
Carvedilol—Propranolol—CYP2D6—Parkinson's disease	0.0002	0.0292	CrCbGaD
Carvedilol—ABCB1—cardiovascular system—Parkinson's disease	0.000198	0.00161	CbGeAlD
Carvedilol—CYP1A1—brain—Parkinson's disease	0.000187	0.00152	CbGeAlD
Carvedilol—CYP2D6—head—Parkinson's disease	0.000187	0.00152	CbGeAlD
Carvedilol—CYP3A4—nervous system—Parkinson's disease	0.00018	0.00146	CbGeAlD
Carvedilol—CYP2D6—nervous system—Parkinson's disease	0.000177	0.00144	CbGeAlD
Carvedilol—ADRA2A—brain—Parkinson's disease	0.000175	0.00142	CbGeAlD
Carvedilol—CYP3A4—central nervous system—Parkinson's disease	0.000173	0.00141	CbGeAlD
Carvedilol—CYP2E1—brain—Parkinson's disease	0.000171	0.00139	CbGeAlD
Carvedilol—CYP2D6—central nervous system—Parkinson's disease	0.00017	0.00138	CbGeAlD
Carvedilol—ABCB1—medulla oblongata—Parkinson's disease	0.000169	0.00138	CbGeAlD
Carvedilol—CYP2D6—cerebellum—Parkinson's disease	0.000167	0.00135	CbGeAlD
Carvedilol—PTGS1—brain—Parkinson's disease	0.000165	0.00134	CbGeAlD
Carvedilol—ABCB1—midbrain—Parkinson's disease	0.000155	0.00126	CbGeAlD
Carvedilol—ABCB1—spinal cord—Parkinson's disease	0.000151	0.00123	CbGeAlD
Carvedilol—Propranolol—ABCB1—Parkinson's disease	0.000143	0.0208	CrCbGaD
Carvedilol—CYP2D6—brain—Parkinson's disease	0.000135	0.0011	CbGeAlD
Carvedilol—ABCB1—head—Parkinson's disease	0.000134	0.00109	CbGeAlD
Carvedilol—ABCB1—nervous system—Parkinson's disease	0.000127	0.00103	CbGeAlD
Carvedilol—ABCB1—central nervous system—Parkinson's disease	0.000123	0.000995	CbGeAlD
Carvedilol—ABCB1—cerebellum—Parkinson's disease	0.00012	0.000973	CbGeAlD
Carvedilol—ABCB1—brain—Parkinson's disease	9.73e-05	0.00079	CbGeAlD
Carvedilol—ADRA2C—Metabolism—ABCB1—Parkinson's disease	8.64e-06	3.78e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	8.63e-06	3.78e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ABCB1—Parkinson's disease	8.63e-06	3.78e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MAOB—Parkinson's disease	8.62e-06	3.77e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	8.57e-06	3.75e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	8.56e-06	3.75e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MAOB—Parkinson's disease	8.55e-06	3.74e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	8.54e-06	3.74e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	8.52e-06	3.73e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	8.51e-06	3.73e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	8.51e-06	3.73e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	8.42e-06	3.68e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CYCS—Parkinson's disease	8.41e-06	3.68e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GSTM1—Parkinson's disease	8.39e-06	3.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	8.38e-06	3.67e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GSTM1—Parkinson's disease	8.37e-06	3.67e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CTGF—Parkinson's disease	8.35e-06	3.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	8.22e-06	3.6e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTA4—Parkinson's disease	8.19e-06	3.59e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NQO1—Parkinson's disease	8.16e-06	3.57e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.13e-06	3.56e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.09e-06	3.54e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—TH—Parkinson's disease	8.05e-06	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GPX1—Parkinson's disease	8.03e-06	3.52e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	8.03e-06	3.51e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GPX1—Parkinson's disease	8.02e-06	3.51e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	8e-06	3.5e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	7.96e-06	3.49e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	7.95e-06	3.48e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	7.85e-06	3.44e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	7.78e-06	3.41e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	7.76e-06	3.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	7.75e-06	3.39e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	7.75e-06	3.39e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	7.73e-06	3.39e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CYCS—Parkinson's disease	7.73e-06	3.38e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NQO1—Parkinson's disease	7.7e-06	3.37e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	7.69e-06	3.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	7.67e-06	3.36e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	7.6e-06	3.33e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	7.59e-06	3.32e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—TH—Parkinson's disease	7.59e-06	3.32e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	7.5e-06	3.28e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—COMT—Parkinson's disease	7.45e-06	3.26e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	7.43e-06	3.25e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	7.43e-06	3.25e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GSTP1—Parkinson's disease	7.42e-06	3.25e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—MTHFR—Parkinson's disease	7.41e-06	3.25e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—MTHFR—Parkinson's disease	7.4e-06	3.24e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MAOA—Parkinson's disease	7.4e-06	3.24e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	7.38e-06	3.23e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	7.36e-06	3.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—HMOX1—Parkinson's disease	7.31e-06	3.2e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	7.31e-06	3.2e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MAOB—Parkinson's disease	7.3e-06	3.2e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYCS—Parkinson's disease	7.28e-06	3.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	7.2e-06	3.15e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	7.2e-06	3.15e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	7.18e-06	3.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	7.1e-06	3.11e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	7.07e-06	3.09e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	7.05e-06	3.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ABCB1—Parkinson's disease	7.02e-06	3.07e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	6.98e-06	3.06e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	6.98e-06	3.06e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.95e-06	3.04e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APOE—Parkinson's disease	6.9e-06	3.02e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	6.89e-06	3.02e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APOE—Parkinson's disease	6.89e-06	3.02e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	6.84e-06	3e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—COMT—Parkinson's disease	6.84e-06	3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GSTM1—Parkinson's disease	6.81e-06	2.98e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GSTP1—Parkinson's disease	6.81e-06	2.98e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP2D6—Parkinson's disease	6.8e-06	2.98e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MAOA—Parkinson's disease	6.79e-06	2.97e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—HMOX1—Parkinson's disease	6.72e-06	2.94e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	6.71e-06	2.94e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DDC—Parkinson's disease	6.7e-06	2.93e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CASP3—Parkinson's disease	6.68e-06	2.93e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CTGF—Parkinson's disease	6.67e-06	2.92e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CASP3—Parkinson's disease	6.67e-06	2.92e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	6.65e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—Parkinson's disease	6.64e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	6.56e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GPX1—Parkinson's disease	6.53e-06	2.86e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	6.52e-06	2.86e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	6.49e-06	2.84e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—COMT—Parkinson's disease	6.45e-06	2.82e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ABCB1—Parkinson's disease	6.45e-06	2.82e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTP1—Parkinson's disease	6.42e-06	2.81e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	6.42e-06	2.81e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MAOA—Parkinson's disease	6.41e-06	2.8e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	6.35e-06	2.78e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—HMOX1—Parkinson's disease	6.33e-06	2.77e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.32e-06	2.77e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CTGF—Parkinson's disease	6.29e-06	2.75e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	6.28e-06	2.75e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GSTM1—Parkinson's disease	6.26e-06	2.74e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	6.24e-06	2.73e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CTGF—Parkinson's disease	6.23e-06	2.73e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP2E1—Parkinson's disease	6.22e-06	2.72e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	6.21e-06	2.72e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	6.2e-06	2.72e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	6.18e-06	2.71e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NQO1—Parkinson's disease	6.15e-06	2.69e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MAPK8—Parkinson's disease	6.14e-06	2.69e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MAPK8—Parkinson's disease	6.13e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	6.11e-06	2.67e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	6.1e-06	2.67e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ABCB1—Parkinson's disease	6.08e-06	2.66e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TH—Parkinson's disease	6.06e-06	2.65e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	6.03e-06	2.64e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MTHFR—Parkinson's disease	6.02e-06	2.64e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GPX1—Parkinson's disease	5.99e-06	2.62e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTM1—Parkinson's disease	5.9e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—INS—Parkinson's disease	5.9e-06	2.58e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—INS—Parkinson's disease	5.89e-06	2.58e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.86e-06	2.57e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—INS—Parkinson's disease	5.85e-06	2.56e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	5.83e-06	2.55e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYCS—Parkinson's disease	5.82e-06	2.55e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	5.81e-06	2.54e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.79e-06	2.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	5.77e-06	2.53e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	5.76e-06	2.52e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NQO1—Parkinson's disease	5.74e-06	2.51e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TH—Parkinson's disease	5.71e-06	2.5e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	5.7e-06	2.5e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.69e-06	2.49e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	5.68e-06	2.49e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TH—Parkinson's disease	5.66e-06	2.48e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GPX1—Parkinson's disease	5.65e-06	2.47e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.64e-06	2.47e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOE—Parkinson's disease	5.61e-06	2.45e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTHFR—Parkinson's disease	5.53e-06	2.42e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYCS—Parkinson's disease	5.48e-06	2.4e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYCS—Parkinson's disease	5.43e-06	2.38e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	5.43e-06	2.38e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	5.43e-06	2.38e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—INS—Parkinson's disease	5.33e-06	2.33e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CTGF—Parkinson's disease	5.33e-06	2.33e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	5.3e-06	2.32e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—INS—Parkinson's disease	5.28e-06	2.31e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTHFR—Parkinson's disease	5.21e-06	2.28e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—INS—Parkinson's disease	5.21e-06	2.28e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—COMT—Parkinson's disease	5.15e-06	2.26e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—Parkinson's disease	5.15e-06	2.25e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTP1—Parkinson's disease	5.13e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MAOA—Parkinson's disease	5.12e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HMOX1—Parkinson's disease	5.06e-06	2.21e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	5.05e-06	2.21e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	5.04e-06	2.21e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	4.96e-06	2.17e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—INS—Parkinson's disease	4.93e-06	2.16e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NQO1—Parkinson's disease	4.91e-06	2.15e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—COMT—Parkinson's disease	4.86e-06	2.13e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—Parkinson's disease	4.85e-06	2.12e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.85e-06	2.12e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TH—Parkinson's disease	4.84e-06	2.12e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.83e-06	2.12e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.82e-06	2.11e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—COMT—Parkinson's disease	4.81e-06	2.11e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTP1—Parkinson's disease	4.79e-06	2.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—INS—Parkinson's disease	4.79e-06	2.1e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MAOA—Parkinson's disease	4.78e-06	2.09e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.77e-06	2.09e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HMOX1—Parkinson's disease	4.72e-06	2.07e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTM1—Parkinson's disease	4.71e-06	2.06e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	4.69e-06	2.05e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYCS—Parkinson's disease	4.64e-06	2.03e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.57e-06	2e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ABCB1—Parkinson's disease	4.53e-06	1.99e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GPX1—Parkinson's disease	4.51e-06	1.98e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.44e-06	1.94e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTM1—Parkinson's disease	4.4e-06	1.93e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—INS—Parkinson's disease	4.4e-06	1.93e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	4.35e-06	1.91e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	4.32e-06	1.89e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—INS—Parkinson's disease	4.31e-06	1.89e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GPX1—Parkinson's disease	4.25e-06	1.86e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GPX1—Parkinson's disease	4.22e-06	1.85e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.19e-06	1.83e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—Parkinson's disease	4.16e-06	1.82e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INS—Parkinson's disease	4.15e-06	1.82e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—COMT—Parkinson's disease	4.11e-06	1.8e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.11e-06	1.8e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.09e-06	1.79e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.08e-06	1.79e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.04e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—INS—Parkinson's disease	4.01e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	4e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	3.97e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	3.94e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.93e-06	1.72e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.92e-06	1.72e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—Parkinson's disease	3.92e-06	1.72e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—Parkinson's disease	3.91e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.9e-06	1.71e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—Parkinson's disease	3.89e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	3.88e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—Parkinson's disease	3.88e-06	1.7e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ABCB1—Parkinson's disease	3.87e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	3.85e-06	1.69e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.83e-06	1.68e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.79e-06	1.66e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTM1—Parkinson's disease	3.76e-06	1.65e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TH—Parkinson's disease	3.73e-06	1.63e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	3.67e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—Parkinson's disease	3.65e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	3.65e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	3.65e-06	1.6e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—Parkinson's disease	3.62e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.61e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.61e-06	1.58e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GPX1—Parkinson's disease	3.6e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.59e-06	1.57e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.58e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	3.57e-06	1.56e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-06	1.48e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.32e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	3.32e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—Parkinson's disease	3.31e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	3.21e-06	1.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	3.19e-06	1.4e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—COMT—Parkinson's disease	3.17e-06	1.39e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.16e-06	1.38e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.15e-06	1.38e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—Parkinson's disease	3.12e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.12e-06	1.36e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—Parkinson's disease	3.1e-06	1.35e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—Parkinson's disease	3.09e-06	1.35e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.99e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.98e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.96e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.95e-06	1.29e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.9e-06	1.27e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.78e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.74e-06	1.2e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—Parkinson's disease	2.64e-06	1.16e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.57e-06	1.12e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.55e-06	1.12e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—Parkinson's disease	2.39e-06	1.05e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	2.33e-06	1.02e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	2.31e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	2.28e-06	9.97e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	2.15e-06	9.43e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	2.12e-06	9.28e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—Parkinson's disease	2.04e-06	8.93e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.88e-06	8.25e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.75e-06	7.66e-06	CbGpPWpGaD
